What is Proton Therapy
Read our Covid-19 policy

Call Now For More Information

General Questions or
Schedule an Appointment


Current Patients


Physician Line


Read our Covid-19 policy

Call to Action: Meeting with Oregon HERC

Call to Action: Meeting with Oregon HERC

In February, the Oregon Health Technology Assessment Subcommittee of the Health Evidence Review Commission voted to recommend against insurance coverage of Proton Beam Therapy for anything other than malignant ocular tumors.  Having treated more than 450 patients from the Northwest, we found this ruling to be both surprising and unfortunate.  For the Oregonians that could potentially benefit from treatment of their cancer with proton beam therapy this development is one we are working hard to reverse. 

On Thursday, June 11, from 1-4pm there will be a meeting in Wilsonville, OR to hear from people responding to the committee’s initial recommendation.  If you live in Oregon, or happen to be near Wilsonville on June 11, please consider attend this meeting to let the committee members know how you and your loved ones have benefited from proton therapy. 

No other state has taken a step like this to prevent proton therapy from being covered by insurance companies. In fact, the Oklahoma legislature and governor recently passed into law a measure that prohibits health insurers from holding proton radiation therapy to a higher standard of clinical effectiveness than other radiation treatment. 

If you are interested in showing your support for proton therapy and speaking at the meeting in Oregon in June please email Stephany Rochon at Stephany.rochon@nyhus.com.